Jacobs Levy Equity Management
NUVB icon

Jacobs Levy Equity Management’s Nuvation Bio NUVB Stock Holding History

Jacobs Levy Equity Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,281,376
Closed -$3.74M – 1024
2024
Q2 		$3.74M Buy
1,281,376
+532,583
+71% +$1.63M 0.02% 494
2024
Q1 		$2.73M Buy
748,793
+537,314
+254% +$1.03M 0.01% 547
2023
Q4 		$319K Sell
211,479
-547,663
-72% -$705K ﹤0.01% 881
2023
Q3 		$1.02M Buy
759,142
+244,558
+48% +$407K 0.01% 676
2023
Q2 		$926K Buy
514,584
+430,156
+509% +$731K 0.01% 709
2023
Q1 		$140K Buy
+84,428
New +$171K ﹤0.01% 923

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Jacobs Levy Equity Management's NUVB Position: Q3 2024 in Review

Jacobs Levy Equity Management sold out of Nuvation Bio (NUVB) in Q3 2024, closing a stake of 1,281,376 shares — an estimated $3.74M sold.

Jacobs Levy Equity Management first reported a position in NUVB in Q1 2023 and held it in 6 quarters. The position peaked at $3.74M in Q2 2024. 154 funds tracked by Wall St. Rank hold NUVB as of Q3 2024.

  • Jacobs Levy Equity Management reported no remaining Nuvation Bio position as of Q3 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 1,281,376 Nuvation Bio shares in Q3 2024, an estimated $3.74M.
  • Jacobs Levy Equity Management first reported a position in Nuvation Bio in Q1 2023 and held it in 6 quarters.
  • Jacobs Levy Equity Management's Nuvation Bio position peaked at $3.74M in Q2 2024.
  • 154 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.